Based on 3 analysts giving stock ratings to Passage Bio Inc in the past month.
In the current month, PASG has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PASG average Analyst price target in the last month is 15.500.
Based on analysts' estimates, PASG EPS is projected to reach -2.550 in FY2026Q4, following reported EPS of -1.467 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -1.47, while Passage Bio IncPASG's earnings per share (EPS) for the previous quarter was USD -2.44. EPS for the next quarter is expected at USD -2.55.